Two neutral copper(I) complexes (1 and 2) bearing deprotonated 2-(4-nitro phenyl) imidazole[4,5-f]-1,10-phenanthroline (NPIP) and different phosphine ligands (bis[2-(diphenylphosphino) phenyl]ether (DPEphos) and PPh 3 ) were synthesized and characterized. The molecular structure of a representative complex (1) was established by single-crystal X-ray diffraction. The complex features the metal in a distorted tetrahedral environment surrounded by two N atoms of the chelating NPIP ligand and two P atoms from DPEphos ligand. The emission spectra show that the two complexes exhibit yellow emission both in anhydrous ether and in the solid powder form. Density functional theory (DFT) calculation was carried out at the B3LYP/6-31G** level to determine the electronic transition within the molecule.
C15H7F 8 O 9 Pr, monoclinic, P21/n (no. 14), a = 6.2167(3) Å,
CCDC no.: 1495690The asymmetric unit of the crystal structure is shown in the gure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Source of material3,4,5,6-Tetra uorobenzene-1,2-dioic acid, (Tfpa, 0.048 g, 0.2 mmol) and sodium formate dihydrate (0.020 g,
C 26 H 42 N4O15Ni, triclinic, P¯ (no. 2), a = 6.9662(8) Å, b = 9.0381(10) Å, c = 13.4863(15) Å,
CCDC no.: 1470488Only the asymmetric unit is shown in the gure. Tables 1-3 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Source of materialThe mixture of Ni(OAc) 2 . 4H 2 O (0.050 g, 0.2 mmol) and H 3 minca (2-(hydroxyl)-6-methyl-isonicotinic acid, 0.039 g,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.